Hoylecohen LLC cut its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,648 shares of the biopharmaceutical company’s stock after selling 4,372 shares during the period. Hoylecohen LLC’s […]